GB Sciences Inc GBLX:OTCQB

RT Quote | Exchange | USD
Last | 05/26/22 EDT
0.0294quote price arrow up+0.0062 (+26.72%)
Volume
596,779
52 week range
0.02 - 0.07
Loading...
  • Open0.0295
  • Day High0.0295
  • Day Low0.0251
  • Prev Close0.0232
  • 52 Week High0.07
  • 52 Week High Date06/09/21
  • 52 Week Low0.02
  • 52 Week Low Date12/20/21

Key Stats

  • Market Cap9.33M
  • Shares Out317.44M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change43.41

KEY STATS

  • Open0.0295
  • Day High0.0295
  • Day Low0.0251
  • Prev Close0.0232
  • 52 Week High0.07
  • 52 Week High Date06/09/21
  • 52 Week Low0.02
  • 52 Week Low Date12/20/21
  • Market Cap9.33M
  • Shares Out317.44M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change43.41

RATIOS/PROFITABILITY

  • EPS (TTM)0.01
  • P/E (TTM)3.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.671M
  • ROE (TTM)-421.46%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)10.78%
  • Net Margin (TTM)-670.49%
  • Debt To Equity (MRQ)102.19%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GB Sciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GB Sciences, Inc. is a phytomedical research and biopharmaceutical drug development company. The Company is engaged in the research and development of plant-based medicines and plans to produce plant-inspired, complex therapeutic mixtures based on its portfolio of intellectual property. It offers artificial intelligence (AI) accelerated drug discovery platform, PhAROS, Phytomedical Analytics for Research Optimization at Scale. The PhAROS platform is a science gateway and...
John Poss
Chairman of the Board, President, Chief Executive Officer
Andrea Small-Howard Ph.D.
President, Chief Science Officer
Zach Swarts CPA
Chief Financial Officer, Treasurer
Address
6450 Cameron St Ste 110A
Las Vegas, NV
89118-4337
United States